Carrie Hersh, DO, MSc, reflects on how the 2024 Annual Meeting of the Consortium of Multiple Sclerosis Centers showcased pivotal clinical insights, with a notable focus on artificial intelligence's role in MS management and medication adherence strategies. Discussions on medications like cladribine, ofatumumab, and ocrelizumab underscored their safety and efficacy across diverse patient populations, offering reassurance to clinicians. Innovative approaches such as at-home phototherapy for managing MS-related symptoms signify promising strides in patient care.
Additionally, the meeting addressed systemic issues like physician burnout, highlighting the importance of support systems for sustaining high-quality care. In summary, the meeting's multidisciplinary discussions promise to enhance patient management practices and address challenges within the MS healthcare landscape.
Medscape © 2024 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Insights Into Multiple Sclerosis Care Through the Lens of CMSC 2024 - Medscape - Jun 21, 2024.
Comments